GIM
BIO icon

Granahan Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Granahan Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,058
Closed -$929K – 184
2020
Q2 		$929K Buy
+2,058
New +$908K 0.03% 169
2018
Q2 		– Sell
-38,065
Closed -$9.52M – 210
2018
Q1 		$9.52M Sell
38,065
-12,285
-24% -$3.13M 0.69% 47
2017
Q4 		$12M Buy
50,350
+18,000
+56% +$4.36M 0.95% 30
2017
Q3 		$7.19M Sell
32,350
-6,705
-17% -$1.51M 0.6% 60
2017
Q2 		$8.84M Buy
39,055
+21,091
+117% +$4.6M 0.81% 37
2017
Q1 		$3.58M Sell
17,964
-157,270
-90% -$30.3M 0.36% 94
2016
Q4 		$31.9M Hold
175,234
– – 1.1% 23
2016
Q3 		$28.7M Sell
175,234
-18,400
-10% -$2.79M 0.94% 25
2016
Q2 		$27.7M Sell
193,634
-19,800
-9% -$2.82M 1.01% 24
2016
Q1 		$29.2M Hold
213,434
– – 1.06% 22
2015
Q4 		$29.6M Sell
213,434
-24,600
-10% -$3.41M 1.02% 22
2015
Q3 		$32M Sell
238,034
-2,600
-1% -$374K 0.99% 24
2015
Q2 		$36.2M Sell
240,634
-29,000
-11% -$4.15M 1.03% 22
2015
Q1 		$36.4M Buy
269,634
+700
+0.3% +$86.8K 1.04% 20
2014
Q4 		$32.4M Hold
268,934
– – 0.95% 31
2014
Q3 		$30.5M Hold
268,934
– – 0.94% 32
2014
Q2 		$32.2M Hold
268,934
– – 0.94% 30
2014
Q1 		$34.5M Buy
268,934
+2,800
+1% +$359K 0.93% 25
2013
Q4 		$32.9M Hold
266,134
– – 0.85% 37
2013
Q3 		$31.3M Sell
266,134
-21,350
-7% -$2.52M 0.83% 38
2013
Q2 		$32.3M Buy
+287,484
New +$33.7M 0.93% 28

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Granahan Investment Management's BIO Position: Q3 2020 in Review

Granahan Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 2,058 shares — an estimated $929K sold.

Granahan Investment Management first reported a position in BIO in Q2 2013 and held it in 21 quarters. The position peaked at $36.4M in Q1 2015. 478 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Granahan Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • Granahan Investment Management sold 2,058 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $929K.
  • Granahan Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 21 quarters.
  • Granahan Investment Management's Bio-Rad Laboratories Class A position peaked at $36.4M in Q1 2015.
  • 478 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Granahan Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.